These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The management of hyperlipidemia: whether, rather than how. Ahrens EH Ann Intern Med; 1976 Jul; 85(1):87-93. PubMed ID: 779574 [TBL] [Abstract][Full Text] [Related]
13. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Carlson LA; Rosenhamer G Acta Med Scand; 1988; 223(5):405-18. PubMed ID: 3287837 [TBL] [Abstract][Full Text] [Related]
15. Editorial: After a coronary. Br Med J; 1975 Apr; 2(5963):103-5. PubMed ID: 1125693 [No Abstract] [Full Text] [Related]
16. [Value of lipid lowering drugs after myocardial infarction: results of the coronary drug project 1975 (author's transl)]. Dubach UC Schweiz Rundsch Med Prax; 1975 Sep; 64(37):1167-8. PubMed ID: 1219703 [No Abstract] [Full Text] [Related]
17. [Present status of antilipemic agents]. Takekoshi N; Murakami E Nihon Rinsho; 1980 Sep; 38(9):3138-48. PubMed ID: 7019504 [No Abstract] [Full Text] [Related]
18. Royal College of Physicians of Edinburgh Consensus Conference on lipid lowering to prevent vascular events 17 & 18 March 1999. Scott Med J; 1999 Jun; 44(3):73-4. PubMed ID: 10461692 [No Abstract] [Full Text] [Related]
19. Clinical trials with gugulipid. A new hypolipidaemic agent. Nityanand S; Srivastava JS; Asthana OP J Assoc Physicians India; 1989 May; 37(5):323-8. PubMed ID: 2693440 [TBL] [Abstract][Full Text] [Related]
20. [Overviews of fibrate]. Tada N Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141 [No Abstract] [Full Text] [Related] [Next] [New Search]